Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001415889-24-026288
Filing Date
2024-11-06
Accepted
2024-11-06 21:03:45
Documents
2
Period of Report
2024-11-05

Document Format Files

Seq Description Document Type Size
1 form3-11072024_021141.html 3  
1 form3-11072024_021141.xml 3 1695
2 ex24-11072024_021141.htm EX-24 6315
  Complete submission text file 0001415889-24-026288.txt   9491
Mailing Address C/O IDERA PHARMACEUTICALS, INC. 505 EAGLEVIEW BLVD., SUITE 212 EXTON PA 19341
Business Address
Kirby John J. (Reporting) CIK: 0001556327 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-38529 | Film No.: 241432779

Mailing Address 10 NORTH HIGH STREET SUITE 200 WEST CHESTER PA 19380
Business Address 10 NORTH HIGH STREET SUITE 200 WEST CHESTER PA 19380 484-453-3300
Verrica Pharmaceuticals Inc. (Issuer) CIK: 0001660334 (see all company filings)

EIN.: 463137900 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)